CINDY SALBINO: Open Payments
NPI 1457048787 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,690 in 124 payments from 16 companies in 2025. Trend: 2023 $173 · 2024 $1,912 · 2025 $2,690
Food & beverage: $2,690
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $533 |
| Otsuka America Pharmaceutical, Inc. | 22 | $371 |
| ABBVIE INC. | 16 | $260 |
| Janssen Pharmaceuticals, Inc | 5 | $227 |
| Alkermes, Inc. | 11 | $213 |
| Neurocrine BioSciences, Inc. | 9 | $211 |
| Lundbeck LLC | 11 | $185 |
| Teva Pharmaceuticals USA, Inc. | 11 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $157 |
| Medtronic, Inc. | 1 | $145 |
Products named: Auvelity, REXULTI, VRAYLAR, ARISTADA, SPRAVATO, INGREZZA, CAPLYTA, INTERSTIM.
Industry payments across CA — which companies pay providers there.
